INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Brain & Mood desk →

1,209 studies · page 39 of 51

2021 / Randomized, double-blind, placebo-controlled crossover trial

Resveratrol supplementation improved cognitive performance, cerebrovascular function, and insulin sensitivity in postmenopausal women.

In a 24-month crossover trial, 125 postmenopausal women aged 45-85 years took 75 mg trans-resveratrol or placebo twice daily for 12 months, followed by the alternative treatment for 12 months. Compared to placebo, resveratrol resulted in a significant 33% improvement in overall cognitive performance (Cohen's d = 0.170, P = 0.005). Resveratrol also improved resting mean cerebral blood flow velocity (d = 0.275, P = 0.001), cerebrovascular responsiveness to hypercapnia (d = 0.307, P = 0.027) and cognitive stimuli (d = 0.259, P = 0.032), fasting insulin (d = 0.174, P = 0.025), and insulin resistance index (d = 0.102, P = 0.034). Women aged 65 and older showed a relative improvement in verbal memory compared to those younger than 65 years.

Thaung Zaw JJ, Howe PR, Wong RH Clin Nutr, 2021. PMID 32900519

2021 / Three-group randomized crossover trial

A plant-based meal altered thalamus perfusion and stimulated greater active GLP-1 secretion than an energy-matched meat meal in men.

In a randomized crossover study, 60 men (with type 2 diabetes, overweight/obese, or healthy controls) consumed an energy- and macronutrient-matched vegan meal (V-meal) or conventional meat meal (M-meal). Thalamus perfusion decreased significantly after the M-meal in men with type 2 diabetes (p = 0.04) and overweight/obese men (p = 0.004), but decreased significantly after the V-meal in healthy controls (p < 0.001). Postprandial active GLP-1 secretion was higher after the V-meal compared with the M-meal by 42% in men with type 2 diabetes (p = 0.003) and by 41% in healthy controls (p = 0.002). Changes in thalamus perfusion after the meals correlated with changes in satiety (r = +0.68; p < 0.01).

Kahleova H, Tintera J, Thieme L, et al. Clin Nutr, 2021. PMID 33081982

2021 / Prospective randomised double-blind sham-controlled study

Whole-body cryotherapy improved immediate recall, orientation, and mood measures in participants with mild cognitive impairment.

In a prospective randomised double-blind sham-controlled trial, 62 participants with mild cognitive impairment were allocated to whole-body cryotherapy (-110 °C to -160 °C; n = 33) or a placebo control group (n = 29). After the 10th session (T2), significant differences favored the cryotherapy group in immediate recall (DemTect) and orientation (TYM). Improvements in mood were detected in self-reported depressive symptoms (T2 p = 0.04; VAS mood T2 p = 0.02; T3 p = 0.07), alongside a significant reduction in BDNF level (p < 0.05).

Rymaszewska J, Lion KM, Stańczykiewicz B, et al. Exp Gerontol, 2021. PMID 33454354

2021 / Randomized, double-blind, placebo-controlled trial

In mild to moderate Alzheimer's disease, 52 weeks of trans-resveratrol decreased CSF MMP-9 by 46% and reduced brain volume compared to placebo.

Thirty patients with moderate to mild Alzheimer's disease were randomized to receive 500 mg trans-resveratrol orally once daily or placebo for 52 weeks. Trans-resveratrol did not lead to statistically significant changes in blood or CSF Aβ40, whereas placebo participants showed significant decreases in CSF (P = 0.024) and plasma Aβ40 (P = 0.036). Compared with placebo, trans-resveratrol resulted in a significant reduction in brain volume at 52 weeks (P = 0.011) and a 46% decrease in CSF matrix metallopeptidase 9 (P = 0.033).

Gu J, Li Z, Chen H, et al. Neurol Ther, 2021. PMID 34402024

2021 / Randomized triple-blind placebo-controlled clinical trial

A 300-mg dose of caffeine did not significantly alter tinnitus-related discomfort or psychoacoustic and electroacoustic measures in chronic tinnitus patients.

Eighty patients with chronic tinnitus followed a 24-hour caffeine-restricted diet and were randomized to receive either a 300-mg caffeine capsule or a placebo (cornstarch). Assessments were performed at baseline and after capsule ingestion using questionnaires (THI, VAS, POMS) and audiometric and otoacoustic evaluations (TEOAE, DPOAE). A significant change in mood (POMS) occurred after caffeine consumption, while THI and VAS scores improved at the second timepoint in both groups. Differences in some audiometry frequencies and otoacoustic measures between baseline and follow-up occurred in both groups but were not clinically relevant, showing that 300 mg of caffeine did not significantly alter tinnitus-related discomfort.

Ledesma ALL, Leite Rodrigues D, Monteiro de Castro Silva I, et al. PLoS One, 2021. PMID 34543285

2021 / Randomized placebo-controlled parallel-arm trial

Daily vinegar ingestion improved depression scores and altered urinary metabolites in healthy college students over four weeks.

In a 4-week placebo-controlled parallel trial, healthy college students were randomized to daily liquid vinegar (1.5 g acetic acid/day; n = 14) or a control pill (0.015 g acetic acid/day; n = 11) with no changes to diet or physical activity. At week four, the change in both POMS depression scores and CES-D scores differed significantly between groups, favoring improved affect in the vinegar group compared to control. Targeted metabolomics indicated metabolite alterations linked to vinegar ingestion, including enzymatic dysfunction in the hexosamine pathway and significant increases in glycine, serine, and threonine metabolism.

Johnston CS, Jasbi P, Jin Y, et al. Nutrients, 2021. PMID 34836275

2020 / Staggered multiple baseline intervention trial

A community-delivered exercise and behavioral intervention improved physical activity and quality of life in persons with dementia and caregiver depression.

A 6-week in-home multicomponent program combining exercise with behavioral/psychosocial training was translated into community delivery by Area Agencies on Aging case managers. Among 255 enrolled dyads, 207 completed the intervention and 140 completed a 13-month follow-up. Persons with dementia had significant increases in physical activity from pre- to posttreatment (p < .001, ES = .54) and at 13 months (p < .01, ES = .21), as well as increased quality of life pre- to posttreatment (p < .001, ES = .29). Caregiver depression also improved from pre- to posttreatment (p = .01, ES = -.18).

Teri L, Logsdon RG, McCurry SM, et al. Gerontologist, 2020. PMID 30304477

2020 / Cluster randomized trial

A potassium-enriched salt substitute significantly increased urinary potassium and reduced systolic blood pressure in rural China.

The Salt Substitute and Stroke Study is an ongoing 5-year cluster randomized trial evaluating potassium-enriched salt substitute versus usual salt in 20,996 individuals across 600 Chinese villages. Intermediate markers assessed over 3 years showed mean differences between the intervention and control groups of -0.32 g (95% CI: -0.68 to 0.05) for 24-hour urinary sodium, +0.77 g (+0.60 to +0.93) for 24-hour urinary potassium, and -2.65 mmHg (-4.32 to -0.97) for systolic blood pressure. Diastolic blood pressure difference was +0.30 mmHg (-0.72 to +1.32). Salt substitute use was 97.5% in the intervention group versus 4.2% in controls, and the overall annual fatal and non-fatal stroke rate across the first 2 years was 3.2%.

Huang L, Tian M, Yu J, et al. Am Heart J, 2020. PMID 31986290

2020 / Randomised double-blind, placebo-controlled trial

Four weeks of daily wild blueberry supplementation significantly reduced self-reported depression symptoms in healthy adolescents.

In a randomized, double-blind, placebo-controlled trial, 64 healthy adolescents aged 12-17 were assigned to receive daily wild blueberry (WBB) supplementation containing about 253 mg anthocyanins or a matched placebo for 4 weeks. Following the intervention, participants receiving WBB had significantly fewer self-reported depressive symptoms than those receiving placebo (P = 0.02, 95% CI -6.71, -5.35). No between-group effects were observed for anxiety symptoms or transient affect.

Fisk J, Khalid S, Reynolds SA, et al. Br J Nutr, 2020. PMID 32151287

2020 / Randomized controlled trial

Resveratrol supplementation improved cognitive performance and attenuated the decline in cerebrovascular responsiveness in postmenopausal women.

Postmenopausal women aged 45-85 years (n = 129) were randomized to receive placebo or 75 mg trans-resveratrol twice daily for 12 months. Compared to placebo, resveratrol improved overall cognitive performance (P < 0.001) and attenuated the decline in cerebrovascular responsiveness (CVR) to cognitive stimuli (P = 0.038). The attenuation of CVR decline was associated with a reduction of fasting blood glucose (r = -0.339, P = 0.023).

Thaung Zaw JJ, Howe PRC, Wong RHX Nutrients, 2020. PMID 32244933

2020 / Double-blind randomized crossover trial

A high-saturated-fat meal and baseline endotoxemia markers were linked to impaired postmeal attentional performance in women.

A double-blind, randomized crossover trial in 51 women evaluated the cognitive effects of a high-saturated-fat meal compared to a high-oleic-sunflower-oil meal 5 hours postmeal, alongside baseline endotoxemia markers. Women had more difficulty distinguishing target stimuli from distractors after the high-saturated-fat meal than after the oleic-sunflower-oil meal (B = 4.44, SE = 1.88, P = 0.02). Higher baseline LBP and LBP:sCD14 were associated with less consistent, slower, and more erratic response times. Significant interactions showed that high baseline LBP and LBP:sCD14 erased between-meal differences, uniformly impairing attention.

Madison AA, Belury MA, Andridge R, et al. Am J Clin Nutr, 2020. PMID 32393980

2020 / Single-blind randomized controlled trial

Drinking lavender herbal tea for two weeks significantly reduced depression and anxiety scores in elderly participants.

A single-blind randomized trial evaluated 60 elderly subjects assigned to receive 2 g lavender teabags twice daily as a decoction for 2 weeks or to an untreated control group. After the intervention, depression scores were significantly lower in the intervention group compared to the control group (16.33 ± 1.49 vs. 18.33 ± 1.84, P < 0.001). Mean differences between intervention and control groups were -2.00 (95% CI: -2.86, -1.13) for depression, -6.40 (95% CI: -9.43, -3.36) for state anxiety, and -4.13 (95% CI: -7.66, -0.60) for trait anxiety.

Bazrafshan MR, Jokar M, Shokrpour N, et al. Complement Ther Med, 2020. PMID 32444033

2020 / Pilot double-blind randomized placebo-controlled trial

Erinacine A-enriched Hericium erinaceus mycelia capsules for 49 weeks improved cognitive scores and contrast sensitivity in patients with mild Alzheimer's disease.

Patients with mild Alzheimer's disease were randomized to receive three 350 mg erinacine A-enriched Hericium erinaceus mycelia (EAHE) capsules per day (5 mg/g erinacine A) or placebo for 49 weeks following a 3-week screening period. After 49 weeks, the EAHE group showed significant improvement in MMSE score, a significant difference in IADL score compared to placebo, and a significant decrease in CASI score was noted only in the placebo group. The EAHE group also achieved significantly better contrast sensitivity and showed differences in biomarkers and neuroimaging ADC values compared to placebo. Four subjects dropped out due to abdominal discomfort, nausea, and skin rash, with no other adverse events reported.

Li IC, Chang HH, Lin CH, et al. Front Aging Neurosci, 2020. PMID 32581767

2020 / Randomized, double-blind pilot trial

Melissa officinalis and Lavandula angustifolia showed effects similar to fluoxetine in treating mild to moderate depression over 8 weeks.

An 8-week double-blind randomized clinical trial compared Melissa officinalis (2 g/day), Lavandula angustifolia (2 g/day), and fluoxetine (20 mg/day) in 45 adult outpatients with mild to moderate major depression. Outcomes were measured at weeks 0, 2, 4, and 8 using the 17-item HAM-D. The study found that M. officinalis and L. angustifolia had an effect similar to fluoxetine (F = 0.131, df = 2,42, p = 0.877). A notable limitation stated by the authors was the absence of a placebo group.

Araj-Khodaei M, Noorbala AA, Yarani R, et al. BMC Complement Med Ther, 2020. PMID 32620104

2020 / Randomized double-blind placebo-controlled trial

Cinnamon supplementation significantly reduced migraine attack frequency, severity, duration, and inflammatory markers (IL-6 and NO) in migraine patients.

Fifty patients with migraine were randomized to receive either cinnamon powder (three capsules/day, each containing 600 mg) or placebo (three capsules/day of corn starch) for 2 months. Compared with the control group, serum concentrations of IL-6 and NO were significantly reduced in the cinnamon group (p < .05), while CGRP levels remained unchanged in both groups. In addition, the frequency, severity, and duration of migraine attacks significantly decreased in the cinnamon group compared to controls.

Zareie A, Sahebkar A, Khorvash F, et al. Phytother Res, 2020. PMID 32638445

2020 / Randomized controlled trial (2 x 2 factorial)

Long-term vitamin D3 supplementation did not reduce the risk of depression or improve mood scores in adults aged 50 or older.

In the VITAL-DEP randomized clinical trial, 18,353 participants aged 50 years or older were assigned to vitamin D3 (2000 IU/d) or placebo for a median duration of 5.3 years. Risk of depression or clinically relevant depressive symptoms did not significantly differ between the vitamin D3 group (12.9/1000 person-years) and placebo (13.3/1000 person-years; HR 0.97, 95% CI 0.87 to 1.09; P = .62). There were also no significant differences in depression incidence, recurrence, or change in PHQ-8 mood scores over time (mean difference 0.01 points, 95% CI -0.04 to 0.05 points).

Okereke OI, Reynolds CF, Mischoulon D, et al. JAMA, 2020. PMID 32749491

2020 / Randomized controlled trial

An 8-week high-polyphenol diet reduced depressive symptoms and improved mental and physical health scores in mildly hypertensive adults.

Ninety-nine mildly hypertensive participants aged 40-65 years completed a 4-week low-polyphenol diet (LPD) washout and were then randomized to either an LPD or a high-polyphenol diet (HPD) for 8 weeks. Participants in the HPD group reported a decrease in depressive symptoms on the Beck Depression Inventory-II, alongside improved physical and mental health component scores on the 36-Item Short Form Survey. No differences were observed for anxiety, stress, self-esteem, or body image perception.

Kontogianni MD, Vijayakumar A, Rooney C, et al. Nutrients, 2020. PMID 32823886

2020 / Randomized, double-blinded, placebo-controlled clinical trial

Supplementation with vitamin D3 or vitamin D-enriched mushrooms showed no significant effect on cognitive function or mood in healthy older adults.

A 6-month trial examined the effects of vitamin D3, enhanced vitamin D2 in a mushroom matrix, standard mushroom, and placebo in 436 healthy adults aged ≥60 years. Total 25-OH-D and 25-OH-D3 levels were maintained in the vitamin D3 arm but decreased significantly (p < 0.05) in the other three arms. There were no significant effects of treatment on any measures of cognitive function or mood over 24 weeks.

Zajac IT, Barnes M, Cavuoto P, et al. Nutrients, 2020. PMID 33339304

2019 / Randomized controlled trial

A Mediterranean-style diet supplemented with fish oil improved diet quality, reduced depression, and improved mental health quality of life in adults with depression.

Adults with self-reported depression were randomized to either a Mediterranean diet intervention (fortnightly food hampers, cooking workshops for 3 months, and fish oil for 6 months) or social groups fortnightly for 3 months. At 3 months, the MedDiet group showed a higher MedDiet score (t = 3.95, P < 0.01), greater reduction in depression (t = -2.24, P = 0.03), and improved mental health QoL (t = 2.10, P = 0.04), with benefits sustained at 6 months. Reduced depression correlated with higher MedDiet score (r = -0.298, P = 0.01), nuts (r = -0.264, P = 0.01), and vegetable diversity (r = -0.303, P = 0.01). Some correlations were also found between increased omega-3, decreased omega-6, and improved mental health.

NANO counterpoint →

Parletta N, Zarnowiecki D, Cho J, et al. Nutr Neurosci, 2019. PMID 29215971

2019 / Randomized controlled trial

Intragastric quinine decreased ghrelin, motilin, prospective food consumption, and hedonic food intake in healthy women.

In 15 healthy women, brain responses to intragastric quinine-hydrochloride (10 µmol/kg) or placebo infusion were recorded using fMRI alongside appetite-related sensations, gastrointestinal hormones, and hedonic food intake. Quinine administration lowered octanoylated ghrelin (P<0.04), total ghrelin (P<0.01), and motilin (P<0.01) plasma levels, alongside lower prospective food consumption ratings (P<0.02) and hedonic food intake (P<0.05). Quinine also increased neural activity in the hypothalamus and hedonic brain regions but decreased activity in the homeostatic medulla (all pFWE-corrected<0.05).

Iven J, Biesiekierski JR, Zhao D, et al. Nutr Neurosci, 2019. PMID 29607741

2019 / Randomized, placebo-controlled, double-blind trial

Soymilk ingestion immediately after exercise enhanced grip strength, walking speed, and endurance in chronic stroke patients.

Twenty-two chronic stroke patients underwent an 8-week rehabilitation exercise intervention (3 sessions/week, 120 min/session) and were randomly assigned to ingest either soymilk (n=11) or a placebo beverage (n=11) immediately post-exercise. Compared with placebo, immediate soymilk ingestion significantly improved hand grip strength (p=0.021), 8-feet walking speed (p=0.019), walking performance per unit lean mass (p=0.024), and 6-minute walk performance (p=0.016). However, changes in lean mass and the total score for the short physical performance battery (SPPB) did not differ between the groups.

Liao YH, Chen CN, Hu CY, et al. NeuroRehabilitation, 2019. PMID 30856124

2019 / Two-year follow-up of an open-label clinical trial

Two years after Microbiota Transfer Therapy, participants with ASD maintained GI improvements, showed further autism symptom gains, and sustained gut changes.

Researchers conducted a two-year follow-up of 18 participants with Autism Spectrum Disorders who previously completed an open-label trial of Microbiota Transfer Therapy (MTT) combining antibiotics, bowel cleanse, acid suppressant, and fecal microbiota transplant. Most improvements in gastrointestinal symptoms were maintained, and autism-related symptoms improved further two years after treatment ended. Important gut microbiota changes persisted, including significant increases in bacterial diversity and relative abundances of Bifidobacteria and Prevotella.

Kang DW, Adams JB, Coleman DM, et al. Sci Rep, 2019. PMID 30967657

2019 / Randomized, double-blind, placebo-controlled parallel-group comparative study

Oral intake of Hericium erinaceus supplements for 12 weeks significantly improved MMSE cognitive function scores.

A randomized, double-blind, placebo-controlled parallel-group comparative study evaluated the effect of Hericium erinaceus fruiting body supplements taken for 12 weeks on cognitive functions. Cognitive performance was assessed using the Mini Mental State Examination (MMSE), Benton visual retention test, and Standard verbal paired-associate learning test (S-PA). MMSE alone showed that oral intake of H. erinaceus significantly improved cognitive functions and prevented deterioration.

Saitsu Y, Nishide A, Kikushima K, et al. Biomed Res, 2019. PMID 31413233

2019 / Mixed-methods comparative study

Walking outdoors provided greater attention restoration and psychological benefits than outdoor golf in a small comparative study.

A mixed-methods study compared psychological responses between two forms of green exercise: golf and walking, in 20 participants (10 per group). Participants in the walking group exhibited significantly greater levels of dissociative cognitions and were the only group to show significant improvements in a directed attention test. The walking group also demonstrated increases in all four subscales of the Exercise-Induced Feeling Inventory, while the golf group showed no significant improvements. Qualitative findings revealed golfers viewed natural elements as obstacles, whereas walkers perceived natural stimuli as evoking positive feelings.

Fraser M, Munoz SA, MacRury S Int J Environ Res Public Health, 2019. PMID 31434352